Bayer hot flashes therapy for breast cancer patients hits main goal in late-stage trial
Bayer (OTCPK:BAYZF) (OTCPK:BAYRY) announced Thursday that elinzanetant, its experimental therapy for hot flashes, reached the ...
News Medical1d
BREEZE 2 Meter from Bayer
Bayer’s BREEZE 2 has a useful on-board disc, containing 10 individual test strips. This means that it is not necessary to fumble around with loose strips and reload the meter every time to test.
Bayer says menopause drug succeeds in breast cancer study
The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...
FierceBiotech7d
JPM25: Bayer moves allogeneic cell therapy into phase 3 Parkinson's trial
Bemdaneprocel will be studied in a sham-surgery controlled, double-blind trial that is expected to start in the first half of ...
Multiple Sclerosis News Today4d
Bayer’s MRI contrast agent effective with 60% less gadolinium: Data
Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, like those done in MS, uses 60% less gadolinium and ...
Daily12d
Bayer partner seeks approval for Darolutamide plus androgen deprivation therapy for metastatic hormone sensitive prostate cancer
Orion's collaboration partner Bayer has submitted an application to the Center of Drug Evaluation (CDE) of China's National ...
Reuters6d
Bayer AG
Bayer pharma chief sees no big acquisitions ... said on Thursday it has appointed Sanofi's Dietmar Berger as its chief medical officer, replacing incumbent Merdad Parsey, who is preparing to ...
Daily8d
Bayer arm Vividion Therapeutics acquires Tavros Therapeutics
Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical company has announced the acquisition of Tavros Therapeutics, ...